Table 4: Posttreatment transcript levels (RQ; normalized to matched ND controls) of MDD patients by remission status

From: Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy

GenePHQ-9>5 (N=13) RQ mean (SE) non-remittedPHQ-95 (N=9) RQ mean (SE) remittedAge-, sex-, race-adjusted P-valueCohen’s D
ADCY31.52 (0.22)1.47 (0.22)0.8790.033
AMFR1.33 (0.24)1.47 (0.25)0.6690.093
ASAH10.90 (0.12)1.38 (0.12)0.0090.630
ATP11C1.12 (0.16)0.62 (0.16)0.0350.486
CD590.92 (0.15)1.13 (0.16)0.3160.221
CDR21.54 (0.26)1.22 (0.27)0.3770.193
CMAS2.13 (0.64)2.69 (0.68)0.5230.139
DGKA3.56 (0.92)3.78 (0.97)0.8630.037
FAM46A1.41 (0.23)1.20 (0.23)0.5180.141
IGSF4A/CADM11.60 (0.44)2.08 (0.44)0.4330.171
KIAA15391.72 (0.21)2.34 (0.22)0.0420.469
MAF1.08 (0.21)1.09 (0.21)0.9630.010
MARCKS1.26 (0.33)2.18 (0.33)0.0580.432
NAGA1.25 (0.21)1.28 (0.21)0.9100.023
PSME11.70 (0.30)2.30 (0.31)0.1480.323
PTP4A31.52 (0.25)1.95 (0.26)0.2060.280
RAPH14.30 (1.29)5.49 (1.36)0.5040.146
SLC4A11.70 (0.52)2.47 (0.54)0.2790.238
TLR71.77 (0.29)1.76 (0.29)0.9790.006
ZNF2911.39 (0.44)1.21 (0.44)0.7710.063
  1. Abbreviations: MDD, major depressive disorder; ND, nondepressed; RQ, relative quantification number. Bold entries represent significant results.